Covello S P, Irvine A D, McKenna K E, Munro C S, Nevin N C, Smith F J, Uitto J, McLean W H
Epithelial Genetics Group, Department of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
J Invest Dermatol. 1998 Dec;111(6):1207-9. doi: 10.1046/j.1523-1747.1998.00445.x.
Epidermolytic palmoplantar keratoderma (EPPK, MIM #144200) is an autosomal dominant disorder in which hyperkeratosis confined to the palms and soles is characterized histologically by cytolysis of suprabasal keratinocytes. Mutations in the keratin 9 gene (KRT9), a type 1 keratin expressed exclusively in the suprabasal keratinocytes of palmoplantar epidermis, have previously been demonstrated in this disorder. Here, we have studied four Northern Irish kindreds presenting with EPPK. By direct sequencing of polymerase chain reaction products, heterozygous missense mutations in exon 1 of KRT9 were detected in all the families. These included a novel mutation M156T; as well as M156V in two kindreds; and R162Q in the remaining family. All mutations were confirmed by reverse strand sequencing and restriction enzyme analysis. The point prevalence of EPPK in Northern Ireland was found to be 4.4 per 100,000. To date, all reported EPPK mutations occur in the helix initiation motif at the start of the central coiled-coil rod domain of K9.
表皮松解性掌跖角化病(EPPK,MIM #144200)是一种常染色体显性疾病,其特征为掌跖部局限性角化过度,组织学表现为基底层上角质形成细胞的溶解。角蛋白9基因(KRT9)突变此前已在该疾病中得到证实,KRT9是一种仅在掌跖表皮基底层上角质形成细胞中表达的I型角蛋白。在此,我们研究了四个患有EPPK的北爱尔兰家族。通过对聚合酶链反应产物进行直接测序,在所有家族中均检测到KRT9外显子1中的杂合错义突变。这些突变包括一个新突变M156T;两个家族中的M156V;以及另一个家族中的R162Q。所有突变均通过反向链测序和限制性酶切分析得到证实。北爱尔兰EPPK的点患病率为每10万人中有4.4例。迄今为止,所有报道的EPPK突变均发生在K9中央卷曲螺旋杆状结构域起始处的螺旋起始基序中。